← Leaderboards
Joseph R Berger
University Of Kentucky
$2,809,271
Attributed
$2,809,271
Total exposure
13
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $403.6K · FY2005–07$500K$375K$250K$125K$0
'05
'06
'07
Funding mix
By agency
NIH$2,809,271 · 13
By mechanism
R01$1,417,257 · 1
M01$569,806 · 7
R21$441,450 · 1
P20$265,520 · 1
R13$115,238 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Kentucky
Same institution · by research overlap
- Bruce Jackson Hinds$2,220,404
- John A Stanford$3,858,416
- Avindra Nath$17,882,997
- Courtney Leah Swadley$75,336
- Malcolm J Avison$6,414,826
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectAids TherapyHuman Therapy EvaluationAids Dementia ComplexAntiaids AgentPathologic ProcessMagnetic Resonance ImagingNuclear Magnetic Resonance SpectroscopyHiv InfectionsBioimaging /Biomedical ImagingAntiparkinson DrugsOral PharyngealAids /Hiv NeuropathyMeeting /Conference /SymposiumProgressive Multifocal LeukoencephalopathySalivaHelper T LymphocyteCombination ChemotherapyAntiviral AgentsPolyomavirus Hominis 2ImmunosuppressionTravelLeukocyte Activation /Transformation
Grant awards (23)
JC VIRUS EXPRESSION IN THE OROPHARYNX AND HIV$1,321
M01 · FY2007 · RR · contact PI
JC VIRUS EXPRESSION IN THE OROPHARYNX AND HIV$44,317
M01 · FY2006 · RR · contact PI
PREDICTORS OF HAART RESPONSIVENESS IN HIV DEMENTIA$14,771
M01 · FY2006 · RR · contact PI
PROTECTIVE ACTIONS OF ESTRADIOL/SERMS ON BRAIN/HIV$265,520
P20 · FY2005 · RR
JC VIRUS EXPRESSION IN THE OROPHARYNX AND HIV$82,123
M01 · FY2005 · RR
PREDICTORS OF HAART RESPONSIVENESS IN HIV DEMENTIA$41,059
M01 · FY2005 · RR
PROSAPTIDE OVER 6 WEEKS OF TREATMENT FOR THE RELIEF OF NEUROPATHIC PAIN/HIV-1$14,933
M01 · FY2005 · RR
MR PREDICTORS OF RESPONSE TO HAART IN HIV DEMENTIA$300,385
R01 · FY2004 · DC
JCV Virus Expression in Oropharynx and HIV$220,950
R21 · FY2004 · DE
JC VIRUS EXPRESSION IN THE OROPHARYNX AND HIV$111,751
M01 · FY2004 · RR
Predictors of HAART Responsiveness in HIV Dementia$72,170
M01 · FY2004 · RR
HIV Neuroprotection Workshop$30,700
R13 · FY2004 · MH
PROSAPTIDE OVER 6 WEEKS OF TREATMENT FOR THE RELIEF OF NEUROPATHIC PAIN/HIV-1$13,969
M01 · FY2004 · RR
MR PREDICTORS OF RESPONSE TO HAART IN HIV DEMENTIA$291,636
R01 · FY2003 · DC
JCV Virus Expression in Oropharynx and HIV$220,500
R21 · FY2003 · DE
MR PREDICTORS OF RESPONSE TO HAART IN HIV DEMENTIA$283,142
R01 · FY2002 · DC
PHASE II TRIAL OF MEMANTINE FOR AIDS DEMENTIA COMPLEX (ACTG301)$73,467
M01 · FY2002 · RR
Neuroscience of HIV Conference$59,538
R13 · FY2002 · MH
MR PREDICTORS OF RESPONSE TO HAART IN HIV DEMENTIA$274,896
R01 · FY2001 · DC
PHASE II TRIAL OF MEMANTINE FOR AIDS DEMENTIA COMPLEX (ACTG301)$73,467
M01 · FY2001 · RR
MR PREDICTORS OF RESPONSE TO HAART IN HIV DEMENTIA$267,198
R01 · FY2000 · DC
PHASE II TRIAL OF MEMANTINE FOR AIDS DEMENTIA COMPLEX (ACTG301)$26,458
M01 · FY2000 · RR
NEUROSCIENCE OF HIV CONFERENCE$25,000
R13 · FY2000 · MH